α-dystroglycan Antibodies

Santa Cruz Biotechnology delivers a wide array of α-dystroglycan monoclonal antibodies for research applications. α-dystroglycan Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). α-Dystroglycan is a vital component of the dystrophin-glycoprotein complex, playing a key role in linking the extracellular matrix to the cytoskeleton of muscle cells. Muscle integrity and function depend on α-dystroglycan, which is essential for the development and maintenance of skeletal muscle and the central nervous system. Research has shown that α-dystroglycan dysregulation is associated with various muscular dystrophies and other diseases, highlighting its significance in both normal physiology and pathological conditions. Scientists worldwide utilize α-dystroglycan monoclonal antibodies to investigate cellular signaling pathways and molecular mechanisms. Understanding α-dystroglycan's role in disease progression helps identify potential therapeutic targets and develop new treatment strategies. Research with α-dystroglycan monoclonal antibodies from Santa Cruz Biotechnology continues to advance scientific knowledge and contribute to breakthrough discoveries in muscle biology and neuroscience.